- Student Records
Programme & Unit Catalogues


PA50186: Cardiovascular therapeutics

Follow this link for further information on academic years Academic Year: 2017/8
Further information on owning departmentsOwning Department/School: Department of Pharmacy & Pharmacology
Further information on credits Credits: 6      [equivalent to 12 CATS credits]
Further information on notional study hours Notional Study Hours: 120
Further information on unit levels Level: Masters UG & PG (FHEQ level 7)
Further information on teaching periods Period:
Modular (no specific semester)
Further information on unit assessment Assessment Summary: CW 100%
Further information on unit assessment Assessment Detail:
  • Assessment Group A: Medicines Optimisation Tool (ass grp A) (CW 40%)
  • Assessment Group A: Case Based Discussion (ass grp A) (CW 20%)
  • Assessment Group A: CARE Tool (CW 10%)
  • Assessment Group A: Service Evaluation (ass grp A) (CW 30%)
  • Assessment Group B: Medicines Optimisation Tool (ass grp B) (CW 40%)
  • Assessment Group B: Case Based Discussion (ass grp B) (CW 20%)
  • Assessment Group B: CARE Tool (ass grp B) (CW 10%)
  • Assessment Group B:PA5186 Guideline Review (ass grp B) (CW 30%)
  • Assessment Group C: Medicines Optimisation Tool (ass grp C) (CW 40%)
  • Assessment Group C: Case Based Discussion (ass grp C) (CW 20%)
  • Assessment Group C: CARE Tool (ass grp C) (CW 10%)
  • Assessment Group C: Patient Safety Review (ass grp C) (CW 30%)
Further information on supplementary assessment Supplementary Assessment:
Like-for-like reassessment (where allowed by programme regulations)
Further information on requisites Requisites: In taking this module you cannot take PA50336 OR take PA50337
Further information on descriptions Description: Aims:
To update underpinning knowledge of pharmacology, physiology and pharmaceutical knowledge in cardiovascular disease management and therapeutics.

Learning Outcomes:
On successful completion of this unit students will be able to:
1. Describe and analyse the role of the healthcare professional / pharmacist in prescribing, administration and monitoring of medication for patients with cardio vascular disease (knowledge and understanding).
2. Explain the disease and patient monitoring factors in this therapeutic area (knowledge and understanding, professional practical skill).
3. Critically evaluate the evidence base for the management of cardiovascular disease (intellectual skill).
4. Reflect on their own practice in supporting patients with these diseases and identify areas for continuous improvement (personal transferable skill).
5. Apply the knowledge gained in this unit to design enhancements to patient facing services and the patient experience (professional practical skill; intellectual skill; knowledge and understanding)

Skills:

* Planning & organisation (Taught / Facilitated)
* Handling information (Taught / Facilitated /Assessed)
* Written communication (Taught / Facilitated /Assessed)
* Working with others (Taught / Facilitated)
* Scientific & practical skills (Taught / Facilitated /Assessed)
* Improving learning & performance (Taught / Facilitated /Assessed)
* Information & communication technology (ICT) (Taught / Facilitated)
* Problem solving (Taught / Facilitated /Assessed)

Content:

* Ischaemic Heart Disease (IHD) - Angina
* Treatment of Angina
* Acute Coronary Syndrome (ACS): Unstable Angina (UA) & non-ST segment elevation Myocardial Infarction (NON-ST-ACS)
* ACS: STEMI
* Secondary Prevention of IHD
* Heart Failure
* Cardiac Arrhythmias
* Hypertension.
Further information on programme availabilityProgramme availability:

PA50186 is Optional on the following programmes:

Department of Pharmacy & Pharmacology

Notes: